ロード中...
Exploring the treatment of COVID‐19 with Yinqiao powder based on network pharmacology
Coronavirus disease 2019 (COVID‐19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). In China, Yinqiao powder is widely used to prevent and treat COVID‐19 patients with Weifen syndrome. In this study, the screening and verification of active ingredients, target selection an...
保存先:
| 出版年: | Phytother Res |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8013442/ https://ncbi.nlm.nih.gov/pubmed/33452734 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ptr.7012 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|